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Childhood trauma, midbrain activation and psychotic
symptoms in borderline personality disorder
K Nicol1, M Pope1, L Romaniuk1 and J Hall1,2,3
Childhood trauma is believed to contribute to the development of borderline personality disorder (BPD), however the mechanism
by which childhood trauma increases risk for speciﬁc symptoms of the disorder is not well understood. Here, we explore the
relationship between childhood trauma, brain activation in response to emotional stimuli and psychotic symptoms in BPD. Twenty
individuals with a diagnosis of BPD and 16 healthy controls were recruited to undergo a functional MRI scan, during which they
viewed images of faces expressing the emotion of fear. Participants also completed the childhood trauma questionnaire (CTQ) and
a structured clinical interview. Between-group differences in brain activation to fearful faces were limited to decreased activation in
the BPD group in the right cuneus. However, within the BPD group, there was a signiﬁcant positive correlation between physical
abuse scores on the CTQ and BOLD signal in the midbrain, pulvinar and medial frontal gyrus to fearful (versus neutral) faces. In
addition there was a signiﬁcant correlation between midbrain activation and reported psychotic symptoms in the BPD group
(Po0.05). These results show that physical abuse in childhood is, in individuals with BPD, associated with signiﬁcantly increased
activation of a network of brain regions including the midbrain in response to emotional stimuli. Sustained differences in the
response of the midbrain to emotional stimuli in individuals with BPD who suffered childhood physical abuse may underlie the
vulnerability of these patients to developing psychotic symptoms.
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INTRODUCTION
Borderline personality disorder (BPD) is a common psychiatric
condition, affecting ~ 1–3% of the general population, and is the
most common personality disorder.1 Individuals with a diagnosis
of BPD experience a range of symptoms, including affective
lability and transient psychotic experiences. This combination of
symptoms led to the initial characterization of the condition as
being on the ‘borderline’ between psychosis and neurosis, giving
rise to its name.2 The aetiology of BPD is complex and both
genetic and environmental factors are recognised as contributing
to risk for the disorder.3,4 Childhood adversity is a widely accepted
risk factor for BPD, with the majority of sufferers disclosing
physical or sexual abuse or emotional neglect in childhood.5,6
Several studies have shown that individuals with BPD have
altered responses to emotional stimuli, including subtle deﬁcits in
recognising negative facial emotions such as disgust and anger.7,8
There is also increasing evidence that neutral or positive facial
expressions are more commonly perceived as negative by those
with BPD.9–11 Furthermore, previous work has revealed a
correlation between facial emotion recognition in the disorder
and experience of childhood physical abuse,12 suggesting a
potential link between childhood adversity and later responses to
emotional stimuli in BPD.
Emotional stress is known to increase the prevalence and
experience of psychotic symptoms in BPD,13,14 illustrating the
sensitivity of sufferers to emotionally arousing stimuli. Research
has indicated that childhood adversity may contribute to risk of
developing psychotic symptoms more generally,15,16 therefore
childhood trauma may contribute to vulnerability for the
development of psychotic symptoms in BPD. The mechanism
associating childhood adversity and the development of psychotic
symptoms in disorders such as BPD is, however, unclear. One
possibility is that early-life experience modiﬁes the function of the
midbrain dopaminergic system. Dopamine signalling dysfunction
has been established as playing an important role in the
symptoms of psychosis experienced in schizophrenia17 and its
receptors are the common target of antipsychotic therapeutics,
which have been shown to have some efﬁcacy in BPD, although
effect sizes are small potentially reﬂecting selective efﬁcacy for
subclasses of symptoms in BPD, such as transient psychotic
symptoms.18–20
Here, we sought to investigate brain activation in response to
emotional stimuli in BPD. On the basis of previous work, we
hypothesised that brain activation in response to emotional faces
in BPD would be modiﬁed by prior experience of childhood
adversity and would relate to current symptom severity, in
particular, severity of psychotic symptoms.
MATERIALS AND METHODS
Participants
Twenty individuals with a diagnosis of BPD were recruited from outpatient
populations. DSM-IV (Diagnostic and Statistical Manual of Mental
Disorders, fourth edition) criteria of BPD was established using the SCID-
II (Structured Clinical Interview for DSM Disorders-II). The BPD group
consisted of 17 females and 3 males, mean age 35.6 (range 20–53 years)
and mean intelligence quotient (IQ) 114.8 (assessed by the National Adult
Reading Test). Of these, 12 were being treated with antipsychotic
medication, and 15 with antidepressant medication. Sixteen healthy
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control participants were recruited from community volunteers, compris-
ing 14 females and 2 males, mean age 35.7 (range 21–51 years) and mean
IQ 113.3. Controls were also assessed for BPD using the SCID-II. Exclusion
criteria for all participants included a history of bipolar I disorder or
schizophrenia, current alcohol or drug dependency, or any neurological
illness. In addition, exclusion criteria for healthy control participants
included a diagnosis of BPD or other personality disorder. Comorbid
psychiatric diagnoses were established using the SCID-I interview (in both
BPD participants and controls) and case note review. In both control and
BPD participants, psychotic symptoms (over the previous 2 weeks) were
rated using the positive symptom component of the Positive and Negative
Symptoms Scale (PANSS),21 current symptoms of depression were rated
using the Hamilton Rating Scale for Depression,22 and current symptoms of
mania were rated using the Young Mania Rating Scale.23 Severity of BPD
symptoms was assessed using the Zanarini Rating Scale for BPD.24
Participants also completed the childhood trauma questionnaire (CTQ), a
self-report measure of incidence and severity of childhood trauma.
The study was approved by the Lothian Research Ethics Committee. All
participants gave written informed consent following a period of at least
24 h consideration with access to the study information sheet. All
participants had the opportunity to discuss the study, and understood
that they were free to withdraw at any time. Participants who withdrew
from the study were not disadvantaged in any way.
fMRI task
In the scanner, participants performed a task that involved viewing
photographs of faces on a computer screen, and selecting whether they
thought the face was male or female, indicated by pressing the
corresponding response button. To ensure that participants had a full
understanding of the task, screen-shots of the images used were shown to
each person before entering the scanner and a complete explanation of
the task was provided. Faces were chosen from the Ekman series of
emotional faces25 and displayed either a fearful or a neutral expression.
The task was made up of six blocks, with each containing six images of
faces. Within each block, all of the faces displayed the same emotion—
either neutral or fearful—with half being female and half male, shown in a
random order. Pictures of the same individuals were shown in both the
fear and neutral blocks, differing only in the emotion portrayed. The blocks
alternated between fear and neutral and were interspersed with rest
blocks lasting 12.5 s during which participants were asked to ﬁxate on a
cross in the centre of the screen. Task blocks commenced with a 1 s visual
prompt (‘Gender?’) followed by each face being shown on the screen for
3.5 s with a 0.5 s inter-stimulus interval between faces. A response (male or
female) had to be made within the 4-s presentation to be registered,
providing a measure of compliance with the task. Two versions of the task
were used, one showing neutral faces in the ﬁrst block, and the other
showing fearful faces in the ﬁrst block. The version of the task (neutral
block ﬁrst or fear block ﬁrst) shown to each participant was randomised.
fMRI data acquisition and analysis
Imaging data was acquired using a 3T Siemens Magnetom Verio Syngo MR
scanner. Functional imaging scans were acquired using the following
parameters: repetition time 1560ms, echo time 26ms, ﬂip angle 66°, 26
slices (slice thickness 5 mm), ﬁeld of view 220× 220 mm, voxel size
3.5 × 3.5 × 5mm. A high resolution T1 MPRAGE structural image was also
acquired with repetition time 2300ms, echo time 2.98ms, ﬂip angle 90′,
ﬁeld of view 256× 256ms, in-plane resolution 256 × 256, 160 interleaved
slices, providing a ﬁnal resolution of 1 × 1× 1mm.
Data processing was carried out using Statistical Parametric Mapping
Software (SPM8, Wellcome Trust Centre for Neuroimaging) and based on
MATLAB software version 7.13 (MathWorks). The ﬁrst six images were
discarded, and the remaining images realigned to the mean image. The
realigned images were then co-registered to the corresponding T1-
weighted anatomical images, and these were spatially normalised into the
Montreal Neurological Institute brain template. Finally, the normalised data
was smoothed with a three-dimensional isotropic Gaussian kernel (8 mm
full width at half maximum).
Statistical analysis was performed in SPM8. At the individual participant
level, the data were modelled with two conditions (‘fear’ and ‘neutral’) each
modelled as a boxcar convolved with a canonical haemodynamic response
function. Parameters representing the participants movement during the
scan were also entered into the model as covariates of no interest. Contrast
images were generated for each participant for the contrasts of interest.
The primary comparison of interest was the contrast of fearful versus
neutral faces. Second-level analysis was carried out to compare differences
within and between groups using t-tests. Within-group regression analysis
was performed across all participants in the BPD group using scores on the
PANSS, Hamilton Rating Scale for Depression, Young Mania Rating Scale
and CTQ, to identify areas of brain activation that correlated with clinical
data. All statistical maps were thresholded at a level of Po0.005
uncorrected and regions were considered signiﬁcant at Po0.05 at the
cluster level, corrected for multiple comparisons. In line with our prior
hypotheses that childhood trauma would have a particular impact on brain
regions involved in emotional and motivation processing, we applied a
small volume correction for activation within the amygdala. A midbrain/
ventral striatum small volume correction was also applied as used
previously,26 supported by previous results indicating a relationship
between childhood trauma and brainstem responses to fearful faces in
women.27
Further statistical analysis was carried out using SPSS software version 19
(IBM, Armonk, NY, USA). Demographic and clinical characteristics between
groups were compared, and activation data was extracted from SPM for use
in SPSS correlation analysis in the BPD group. Causal mediation analysis was
carried out using R version 3.0.2 to investigate the link between childhood
trauma, midbrain activation and psychotic symptoms.
RESULTS
Demographic, clinical and behavioural data
There was no difference in age (t1,36 = 3.82, P= 0.97; range 20–53
in controls and 21–51 in the BPD group) or IQ (t1,31 = 0.56, P= 0.58)
between groups. Five control participants did not complete the
National Adult Reading Test and these individuals were excluded
from IQ analysis. The BPD group scored signiﬁcantly higher on the
Hamilton Rating Scale for Depression (t1.36 = 8.07, Po0.001),
Young Mania Rating Scale (t1,36 = 2.92, Po0.01), PANSS (t1,36
=− 4.34, Po0.001) and CTQ (t1,35 = 6.99, Po0.001) than the
control group. All participants showed good engagement with the
fMRI task (99.4% overall response rate). There was no difference
between participants with BPD and control participants in terms
of their reaction times or accuracy for gender judgements for
neutral faces (P40.1 for both). However, participants with BPD
were marginally slower than controls when making gender
judgements on fearful faces (1.54 s versus 1.38 s; t1,35 = 2.27,
Po0.05) and were less accurate in making these judgements
(93% accuracy versus 99% accuracy, t1,35 = 2.21, Po0.05).
Participant information is detailed in Table 1.
Brain activation to emotional faces
Across all participants, there were signiﬁcant bilateral increases in
activation when viewing fearful compared with neutral faces in
the fusiform gyrus bilaterally (Po0.001, KE = 401, Z= 4.21, co-
ordinates 30, − 82, − 2 and P= 0.001, KE = 240, Z= 5.34, co-
ordinates − 27, − 82, − 2) and amygdala bilaterally (within
amygdala small volume correction, P= 0.04, KE = 7, Z= 3.25, co-
ordinates 18, 4, − 20 and P= 0.02, KE = 17, Z= 3.54, co-ordinates
− 24, − 10, − 14). There was also signiﬁcant activation in the medial
frontal gyrus (P= 0.003, KE = 192, Z= 4.41, co-ordinates 42, 11, 25).
Comparing activation between groups, signiﬁcantly greater BOLD
responses were noted in control participants than in those with
BPD in the right cuneus (P= 0.03, KE = 238, Z= 3.72, co-ordinates
− 18, − 88, 7) to fearful versus neutral faces (Figure 1).
Effect of childhood experience
We next investigated the relationship between experience of
childhood trauma, as measured by the CTQ, and brain activation
to emotional faces in those with a diagnosis of BPD. We
speciﬁcally focussed on childhood experiences of physical abuse
and emotional abuse based on previous behavioural data showing
that these areas of childhood experience speciﬁcally had an effect
on later responses to emotional faces, a ﬁnding that was not
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replicated with other subscales of the CTQ.12 Regression of scores
for prior physical abuse taken from the CTQ against brain
activation to fearful (versus neutral) faces revealed a network of
brain activation related to increased physical abuse scores in BPD.
Increased activation as a function of severity of prior physical
abuse was found in the medial frontal gyrus (P= 0.04, KE = 240,
Z= 3.82, co-ordinates − 24, 44, − 2), pulvinar (P= 0.007, KE = 348,
Z= 3.93, co-ordinates − 3, − 25, 13) and cerebellum (P= 0.03, KE
= 246, Z= 3.66, co-ordinates 6, − 52, − 17; Figure 2). Following
application of a midbrain/ventral striatum mask,26 signiﬁcant
activation was also noted in the midbrain (P= 0.04, KE = 82,
Z= 3.66, co-ordinates − 6, − 16, − 14; Figure 3). The relationship
between physical abuse and midbrain activation remained
signiﬁcant after controlling for other CTQ subscales. There were
no signiﬁcant correlations of brain activation with emotional
abuse scores or total CTQ scores, supporting the speciﬁcity of the
ﬁndings to physical abuse.
Brain activation and correlation with psychotic symptoms
We sought to determine whether increased midbrain activation in
participants with BPD who had suffered physical abuse in
childhood was related to current psychotic symptoms. Analysis
of extracted data for the peak voxel of activation within the
midbrain within the BPD group showed a signiﬁcant correlation
with reported positive psychotic symptoms as assessed by the
PANSS (Po0.05, r= 0.45, n= 20), with a particularly strong
association seen between midbrain activation and the PANSS
item for persecutory beliefs (P6). No association was seen between
peak activation in the pulvinar, medial frontal gyrus or cerebellum
and psychotic symptoms.
We ﬁnally investigated whether midbrain activation mediated a
relationship between childhood physical abuse and psychotic
symptoms in adulthood in our BPD sample. Mediation analysis
revealed a strong trend towards signiﬁcance (P= 0.06), indicating
that childhood physical abuse may increase later psychotic
symptoms through alterations in midbrain activity.
Effects of medication status
We ﬁnally determined whether any of the above effects could be
accounted for by medication effects within the BPD group.
Analysis of extracted data demonstrated that there were no
diffrerences between BPD participants treated with antidepres-
sants or antipsychotics and those not treated with such
medications in terms of brain activation in any of the key areas
of activation including the cuneus and midbrain.
DISCUSSION
We have investigated brain responses to fearful facial stimuli in
individuals with BPD and their relationship to self-reported
experiences of childhood trauma and psychotic symptoms. Group
differences in brain activation between participants suffering from
the disorder and controls viewing emotional faces were restricted
Table 1. Participant information
Demographics BPD Healthy control P
n mean s.d. n mean s.d.
Age 20 35.8 8.6 16 34.8 9.6 0.97
IQ 20 114.8 7.9 16 114.5 6 0.58
CTQ (total) 20 52.9 19.8 16 13.1 11.5 o0.001
Emotional abuse 11.4 3.3 3.9 1.9 o0.001
Physical abuse 12.5 7.5 5.5 1.3 o0.01
Sexual abuse 15.7 8.7 6.3 4.2 o0.01
Emotional neglect 7.4 2.5 2.1 0.3 o0.001
Physical neglect 5.9 3.7 3.5 0.9 0.06
HAM-D 20 15.5 8.6 16 0 0 o0.001
YMRS 20 2.1 3.1 16 0 0 o0.01
PANSS above baseline 20 2.6 2.5 16 0 0 o0.001
ZAN-BPD 20 13.7 6.7 16 0 0 o0.001
Medication n %
Antipsychotic
medication
12 60
Antidepressant
medication
15 75
Comorbid diagnoses n %
Total 17 85
Depression 4 20
Bipolar affective
disorder Ii
4 20
Eating disorder 3 15
PTSD 2 10
OCD 2 10
Other 2 10
Abbreviations: BPD, borderline personality disorder; CTQ, childhood trauma
questionnaire; HAM-D, Hamilton Rating Scale for Depression; IQ, NART IQ;
OCD, obsessive compulsive disorder; PANSS above baseline, PANSS positive
symptom score above counting lowest rating as 0 not 1; PTSD, post
traumatic stress disorder; ZAN-BPD, Zanarini Borderline Personality Disorder
Symptom rating scale; YMRS, Young Mania Rating Scale.
Figure 1. Regions of statistically greater activation in the right
cuneus in the control group compared with the borderline
personality disorder group, in response to fearful versus neutral
faces. Red areas show activation differences meeting threshold
Po0.005 across whole brain, superimposed on the mean T1 image.
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to the cuneus. However, within the BPD group, a strong
relationship was observed between childhood experiences of
physical abuse and greater activation of the midbrain, medial
frontal gyrus, pulvinar and cerebellum to emotional stimuli.
Midbrain activation to emotional faces was additionally correlated
with severity of current psychotic symptoms, especially persecu-
tory beliefs. These results support an association between
childhood trauma and long-lasting changes in brain responses
to emotional stimuli. Although it is not possible to ascertain from
the current study whether this effect is speciﬁc to BPD, such
changes may contribute to the development of psychotic
symptoms in adulthood, particularly at times of negative
emotional stimulation.
Direct comparison of brain activation in participants with BPD
compared with controls viewing fearful faces revealed group
differences in the activity of the cuneus. This difference may be
attributed to the role of the cuneus in visual processing,
potentially reﬂecting altered responsiveness of individuals with
BPD to visual cues such as those presented, which could be
perceived as negative or threatening. Previous studies involving
BPD populations have also reported decreased activation28 and
reduced functional connectivity29 of the cuneus in this disorder.
The cuneus is also believed to have a role in theory of mind—the
ability to attribute mental states to others—and studies involving
healthy populations have revealed increased activity in this region
during tasks involving theory of mind.30,31 Taken together with
our results, these ﬁndings suggest that cuneus dysfunction may
contribute to deﬁcient emotional processing in BPD.
Previous studies have identiﬁed a relationship between child-
hood trauma and altered emotion regulation, as well as
behavioural responses to emotional stimuli in BPD.12,32 Childhood
adversity has also been strongly associated with the development
of symptoms of the disorder, and more generally with the
development of psychotic symptoms across a range of
disorders.5,6,15 We investigated the relationship between child-
hood adversity and brain responses to emotional stimuli in
participants with BPD. Using this analysis, we identiﬁed a
signiﬁcant association between brain activation in a network of
regions including the midbrain, medial frontal gyrus, pulvinar and
cerebellum, and previous experience of physical abuse as
measured by the CTQ.
The midbrain is the key site of dopaminergic afferents to the
limbic system and is known to be involved in emotion
processing.33 Dysfunction of this brain region is widely theorised
to contribute to the development of psychotic symptoms in
schizophrenia.17,34 The present results suggest that, in patients
with BPD, childhood physical abuse results in an increased
response of the midbrain to negative (fearful) emotional stimuli.
We also found that individuals with BPD who experienced
childhood physical abuse may be particularly vulnerable to the
development of psychotic symptoms, via midbrain dysfunction,
when exposed to negative emotional stimuli in adulthood. These
ﬁndings provide a potential biological rationale for the use of
antipsychotic medications to ameliorate psychotic symptoms in
BPD.35 However, fMRI is only an indirect measure of dopamine
Figure 2. Regions of activation in medial frontal gyrus and
cerebellum which correlated signiﬁcantly with childhood physical
abuse, as assessed by the CTQ, in those with borderline personality
disorder. Red areas show activation meeting threshold Po0.005
across whole brain, superimposed on the mean T1 image. CTQ,
childhood trauma questionnaire.
Figure 3. Region of activation in midbrain, which correlated
signiﬁcantly with childhood physical abuse, as assessed by the
CTQ, in those with borderline personality disorder. Red areas show
activation meeting threshold Po0.005 within a midbrain/ventral
striatum mask, superimposed on the mean T1 image. CTQ, child-
hood trauma questionnaire.
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system activation and the results would be strengthened by future
studies using more direct measures such as positron emission
tomography. Furthermore, the psychotic symptoms reported by
BPD sufferers were generally at the milder end of the range of
severity as assessed by the PANSS, and it may be these symptoms
such as suspiciousness and paranoid ideation, to which BPD
sufferers are particularly vulnerable.
The present study identiﬁed additional areas of increased BOLD
activation in response to fear versus neutral faces that correlated
signiﬁcantly with physical abuse in the BPD group. Greater
activation was observed in the pulvinar, which is believed to be
responsible for relaying fear information to the amygdala.36 A
study with healthy volunteers found that the pulvinar was
activated speciﬁcally in response to fearful faces,37 highlighting
its importance in fear responses. The increased pulvinar activation
observed in the current study may indicate a heightened fear
response in individuals with BPD who suffered physical abuse in
childhood. This is in keeping with previous work, which found that
those with this diagnosis tended to judge neutral social cues as
more threatening compared with controls.12 The correlation of
activation of the cerebellum to emotional stimuli with physical
abuse is likely to reﬂect the increasingly recognised role of the
cerebellum in processing affective and social information, and, in
particular, in fearful emotion processing.38,39 The frontal gyrus has
been implicated as being involved in facial emotion processing,
particularly in differentiating between neutral faces and those
showing emotion,40 and increased activation in this area may
reﬂect heightened sensitivity to emotional compared with neutral
facial expressions.
The speciﬁcity of the current ﬁndings to physical abuse warrants
further comment. It is possible that physical abuse has a
particularly strong relationship with subsequent brain responses
to fear-related stimuli in adulthood, resulting in the activation of
limbic/motivational ‘salience’ networks. However, an alternative
possibility is that physical abuse is most clearly recalled by
participants, or has greater discriminatory power due to the range
of responses reported. However as other behavioural changes,
such as social judgement decision biases, are more strongly
correlated with sexual abuse in BPD,12 we suggest that physical
abuse may have a particular impact on fear processing in
adulthood.
The present study demonstrates a signiﬁcant association
between childhood trauma and brain activation in BPD, and
suggests a link between childhood physical abuse and psychotic
symptoms in adulthood, which may be mediated through altered
midbrain activation. To the authors' knowledge, this is the ﬁrst
time such correlations have been identiﬁed in a BPD population.
These results may help explain the sensitivity of many individuals
with the disorder to negative emotional stimuli, and, in particular,
the tendency of sufferers to develop psychotic symptoms at times
of emotional stress. Altered midbrain activation may also underlie
the response to antipsychotic treatment seen in patients with
BPD. The results also support the use of early psychological
interventions in individuals with this diagnosis to ameliorate
negative responses to environmental stimuli, and highlight the
importance of managing emotional stressors in sufferers. They
illustrate the key role of early-life experience in modulating
midbrain activation, which may be of relevance to a range of
psychiatric disorders, particularly those in which psychotic
symptoms are a signiﬁcant feature.
There are some limitations to the study, which should be
acknowledged. First, the majority of participants in the BPD group
were taking medication at the time of the study. It is possible,
though unlikely, that medication effects may have contributed to
the group difference in activation noted in the cuneus and in the
correlations noted between brain activation and childhood
trauma. However, the likelihood of this is very low, given the
variation of medication use across participants and the speciﬁc
effects of childhood abuse seen in the within-group correlation
analyses. Second, the BPD participants in the current study were
predominantly female consistent with clinical populations in the
UK but not with epidemiological studies, which point to a more
balanced sex ratio.3 Participants in the current study also had a
relatively broad age range, but this was closely balanced across
groups. Third, the participants in the current study were of higher-
than-average IQ, potentially representing the local demographics
and a tendency for more able individuals to take part. Fourth, the
ﬁndings within the midbrain were within an a priori area of
interest, although these ﬁndings were strengthened by the
subsequent speciﬁc association of activation in this region with
severity of psychotic symptoms. Fifth, there was insufﬁcient range
of CTQ scores in the control population to determine whether the
relationship between physical abuse and midbrain activation is
also seen in individuals without BPD, which would require larger
samples. Sixth, although the current research has identiﬁed a
trend towards midbrain activation mediating the relationship
between childhood physical abuse and psychotic symptoms in
adulthood in BPD, this ﬁnding fell just short of formal statistical
signiﬁcance. Further investigation is required, ideally using larger
sample sizes, to better determine the role of the midbrain in the
development of psychotic symptoms. Similarly, this relationship in
other psychiatric disorders should be investigated to elucidate
whether this effect is speciﬁc to BPD.
Nonetheless, the present ﬁndings highlight the damaging
effects of adverse childhood experiences into adulthood, and
support early intervention for those at risk of developing BPD.
Early intervention strategies, for example, engagement with
families or carers, family intervention and tailored psychotherapy
may prove effective. Our results also provide some support for the
use of drugs targeting the dopamine system in BPD, but more
research is needed.41 Overall, the study emphasises the impor-
tance of continuing biological research into BPD to further our
understanding of the condition and to identify suitable ther-
apeutic or alternative therapies for those suffering from the
disorder.
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